Devin C Flaherty
Overview
Explore the profile of Devin C Flaherty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun V, Guthrie K, Crane T, Arnold K, Colby S, Freylersythe S, et al.
Cancer
. 2024 Feb;
130(13):2384-2394.
PMID: 38386696
Background: Survivors of rectal cancer experience persistent bowel dysfunction after treatments. Dietary interventions may be an effective approach for symptom management and posttreatment diet quality. SWOG S1820 was a pilot...
2.
Krouse R, Anderson G, Arnold K, Thomson C, Nfonsam V, Al-Kasspooles M, et al.
Lancet Gastroenterol Hepatol
. 2023 Aug;
8(10):908-918.
PMID: 37541263
Background: Malignant small bowel obstruction has a poor prognosis and is associated with multiple related symptoms. The optimal treatment approach is often unclear. We aimed to compare surgical versus non-surgical...
3.
Flaherty D, Bilchik A
Ann Surg Oncol
. 2018 Dec;
26(Suppl 3):535-536.
PMID: 30523469
No abstract available.
4.
Flaherty D, Jalas J, Sim M, Stojadinovic A, Protic M, Lee D, et al.
Ann Surg Oncol
. 2018 Mar;
25(5):1374-1380.
PMID: 29532344
Background: The association between tumor mismatch repair status and obesity in colon cancer is not well understood. The authors of this study hypothesized that mismatch repair deficiency in colon cancer...
5.
Deutsch G, Flaherty D, Kirchoff D, Bailey M, Vitug S, Foshag L, et al.
JAMA Surg
. 2017 Apr;
152(7):672-678.
PMID: 28384791
Importance: Systemic therapy for metastatic melanoma has evolved rapidly during the last decade, and patient treatment has become more complex. Objective: To evaluate the survival benefit achieved through surgical resection...
6.
Jones M, Torisu-Itakura H, Flaherty D, Schoellhammer H, Lee J, Sim M, et al.
Am Surg
. 2016 Oct;
82(10):1009-1013.
PMID: 27779995
The impact on survival of a second primary melanoma (SPM) is unclear. We used our melanoma center's database to examine clinicopathologic risk factors and outcomes of stage 0 to IV...
7.
Flaherty D, Bawa R, Burton C, Goldfarb M
Ann Surg Oncol
. 2016 Sep;
24(1):84-90.
PMID: 27650826
Background: Breast cancer is one of the most common cancers in female adolescent and young adults (AYA; age 15-39 years). However, few data exist detailing either in situ or invasive...
8.
Flaherty D, Lavotshkin S, Jalas J, Torisu-Itakura H, Kirchoff D, Sim M, et al.
J Am Coll Surg
. 2016 Jun;
223(1):134-40.
PMID: 27282965
Background: Retrospective data indicate that immunoprofiling of T cell markers can be prognostic in colon cancer. Prospective T cell immunoprofiling of colon cancer has not been well defined for patients...
9.
Huynh K, Lee D, Lau B, Flaherty D, Lee J, Goldfarb M
J Am Coll Surg
. 2016 May;
223(3):485-92.
PMID: 27238874
Background: Appropriate use of laparoscopic adrenalectomy (LA) for adrenocortical carcinoma (ACC) remains controversial because complete resection with negative margins is the best chance for potential cure. This study compared the...
10.
Lee D, Lau B, Huynh K, Flaherty D, Lee J, Stern S, et al.
J Am Coll Surg
. 2016 May;
223(1):9-18.
PMID: 27236435
Background: Whether patients with positive SLNB should undergo complete lymph node dissection (CLND) is an important unanswered clinical question. Study Design: Patients diagnosed with positive SLNB at a melanoma referral...